LEON GALLOW: Open Payments
NPI 1568554897 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$99 in 6 payments from 5 companies in 2025. Trend: 2023 $331 · 2024 $247 · 2025 $99
Food & beverage: $99
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $38 |
| Seqirus USA Inc | 1 | $17 |
| Ardelyx, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: Rybelsus, Fluad, IBSRELA, OTEZLA, CAPLYTA.
Industry payments across LA — which companies pay providers there.
